Cosmecca Korea Balance Sheet Health
Financial Health criteria checks 6/6
Cosmecca Korea has a total shareholder equity of ₩242.2B and total debt of ₩105.5B, which brings its debt-to-equity ratio to 43.6%. Its total assets and total liabilities are ₩432.6B and ₩190.5B respectively. Cosmecca Korea's EBIT is ₩49.2B making its interest coverage ratio 13.3. It has cash and short-term investments of ₩39.4B.
Key information
43.6%
Debt to equity ratio
₩105.53b
Debt
Interest coverage ratio | 13.3x |
Cash | ₩39.44b |
Equity | ₩242.17b |
Total liabilities | ₩190.46b |
Total assets | ₩432.63b |
Recent financial health updates
Recent updates
Is Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Trading At A 44% Discount?
Apr 19Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Mar 25We Like These Underlying Return On Capital Trends At Cosmecca Korea (KOSDAQ:241710)
Mar 01Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 37% Above Its Share Price
Mar 23Cosmecca Korea (KOSDAQ:241710) Share Prices Have Dropped 53% In The Last Three Years
Mar 04When Should You Buy Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?
Feb 17The Returns At Cosmecca Korea (KOSDAQ:241710) Provide Us With Signs Of What's To Come
Feb 02Should You Use Cosmecca Korea's (KOSDAQ:241710) Statutory Earnings To Analyse It?
Jan 18Is Cosmecca Korea (KOSDAQ:241710) Using Too Much Debt?
Jan 04What You Need To Know About Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Investor Composition
Dec 23Are Investors Undervaluing Cosmecca Korea Co., Ltd. (KOSDAQ:241710) By 32%?
Dec 08Cosmecca Korea's (KOSDAQ:241710) Stock Price Has Reduced 58% In The Past Three Years
Nov 25Financial Position Analysis
Short Term Liabilities: A241710's short term assets (₩221.2B) exceed its short term liabilities (₩154.6B).
Long Term Liabilities: A241710's short term assets (₩221.2B) exceed its long term liabilities (₩35.9B).
Debt to Equity History and Analysis
Debt Level: A241710's net debt to equity ratio (27.3%) is considered satisfactory.
Reducing Debt: A241710's debt to equity ratio has reduced from 46.6% to 43.6% over the past 5 years.
Debt Coverage: A241710's debt is well covered by operating cash flow (39.8%).
Interest Coverage: A241710's interest payments on its debt are well covered by EBIT (13.3x coverage).